MDC’s burden of illness study
La française suit
If you have a neuromuscular disorder or care for someone who does, we need your help! You are invited to participate in a questionnaire on the costs of living with a neuromuscular disorder and the impact of neuromuscular disorders on everyday life.
This is a research project being conducted by Muscular Dystrophy Canada. The purpose of this study is to better understand the impact of neuromuscular disorders on individuals and their caregivers in Canada, which can help to inform future programs, services and policies.
If you live in Canada and:
– Are 17 years and older and live with a neuromuscular condition OR
– A parent of a child (age 2–16 years) with a neuromuscular condition OR
– A family member/caregiver to someone living with a neuromuscular disorder (age 0+)
The survey should take approximately one hour to complete. If necessary, you can save and return to the survey at any time.
You can complete the questionnaire online at oursurvey.ca/MDC
You can also email or call 1 800 567-2873 ext. 9037 to schedule a time to complete the questionnaire by phone.
Si vous avez une maladie neuromusculaire ou si vous vous occupez d’une personne qui en est atteinte, nous avons besoin de vous! Nous vous invitons à répondre à un questionnaire sur les coûts qu’implique le fait de vivre avec une maladie neuromusculaire et l’impact de ces maladies sur la vie quotidienne.
Ce projet de recherche est une initiative de Dystrophie musculaire Canada et vise à mieux comprendre l’impact des maladies neuromusculaires sur les personnes et leurs proches aidants au Canada. Cette étude nous aidera à effectuer des changements positifs et guidera nos futurs programmes, services et politiques.
Si vous vivez au Canada et :
– Que vous avez 17 ans ou plus et avez une maladie neuromusculaire OU
– Que vous êtes parent d’un enfant de 2 à 16 ans atteint d’une maladie neuromusculaire OU
– Que vous êtes un proche ou une proche aidante d’une personne atteinte d’une maladie neuromusculaire
Répondre à ce questionnaire devrait vous prendre environ une heure. Au besoin, vous pouvez en tout temps sauvegarder vos réponses et compléter le sondage plus tard.
Vous pouvez répondre à notre questionnaire en ligne oursurvey.ca/MDC
Vous pouvez aussi répondre à ce sondage par téléphone en prenant d’abord rendez-vous, soit par courriel à , soit par téléphone au 1 800 567-2873, poste 9037.
Read next...
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.
MICYRN Secures $20 Million Grant from CIHR for a Pediatric Rare Disease Clinical Trials and Treatment Network
The NMD4C are excited to share that MICYRN’s success in securing a $20 million grant from CIHR Institute of Genetics to support the development and execution of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network.